IHC
Roche Nabs FDA Approval for Ventana PD-L1 Test as CDx for Libtayo
The immunohistochemistry test is used to detect programmed death-ligand 1 protein in non-small cell lung carcinoma patients.
NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug
The pharma firm will cover the cost for eligible ovarian cancer patients to be tested using the companion diagnostic to its new drug Elahere.
Roche Nabs FDA Approval for Ventana Test as CDx for Elahere
The immunohistochemistry-based test detects the folate receptor 1 protein that is over-expressed in most ovarian cancers.
Boston Cell Standards Gains 510(k) Clearance for Breast Cancer Test Control Panels
The firm said the immunohistochemistry panel, named IHControls, will safeguard against quality problems that could lead to incorrect results.
In new guidelines, an expert panel recommended IHC and PCR for certain cancer types and pointed out knowledge gaps supporting NGS in other settings.
Jun 25, 2018